Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Malik Rajiv
   2. Issuer Name and Ticker or Trading Symbol
MYLAN INC. [MYL] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
President
(Last)
(First)
(Middle)
1000 MYLAN BLVD		 3. Date of Earliest Transaction (Month/Day/Year)
01/29/2015
(Street)

CANONSBURG, PA 15317		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/29/2015   M   36,918 (1) A $ 0 380,154 D  
Common Stock 01/29/2015   A   136,409 (2) A $ 0 516,563 D  
Common Stock 01/29/2015   F   58,917 (3) D $ 54.885 457,646 D  
Common Stock 01/29/2015   M   40,230 (4) A $ 23.44 497,876 D  
Common Stock 01/29/2015   M   56,748 (5) A $ 30.9 554,624 D  
Common Stock 01/29/2015   F   65,394 (6) D $ 54.885 489,230 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $ 0 01/29/2015   M     36,918 01/29/2015(7)   (7) Common Stock 36,918 $ 0 0 D  
Employee Stock Option - Right to Buy $ 23.44 01/29/2015   M     40,230 01/29/2015 02/22/2022 Common Stock 40,230 $ 0 80,460 D  
Employee Stock Option - Right to Buy $ 30.9 01/29/2015   M     56,748 01/29/2015 03/06/2023 Common Stock 56,748 $ 0 28,374 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Malik Rajiv
1000 MYLAN BLVD
CANONSBURG, PA 15317		   X     President  

Signatures

 /s/ Bradley L. Wideman, by power of attorney   02/02/2015
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Represents acquisition of shares of Mylan common stock upon vesting of RSUs.
(2) Represents acquisition of shares of Mylan common stock upon vesting of PRSUs. Each PRSU represents the right to receive shares of Mylan common stock. The PRSUs were granted on February 22, 2012, March 6, 2013 and March 5, 2014.
(3) Represents withholding of shares of Mylan common stock for the tax liability associated with the vesting of RSUs and PRSUs.
(4) Represents acquisition of Mylan common stock upon exercise of stock options granted on February 22, 2012.
(5) Represents acquisition of Mylan common stock upon exercise of stock options granted on March 6, 2013.
(6) Represents withholding of shares of Mylan common stock to satisfy the exercise price and tax liability associated with the exercise of stock options granted on February 22, 2012 and March 6, 2013.
(7) Each RSU represents the right to receive one share of Mylan common stock. The RSUs were granted on February 22, 2012, March 6, 2013 and March 5, 2014.
 
Remarks:
The transactions described on this Form 4 are described in the proxy statement filed by Mylan Inc. ("Mylan") on December 24, 2014 and the Form 8-K filed by Mylan on November 5, 2014.  In connection with the proposed acquisition (the "Transaction") by a new public company organized in the Netherlands of both Mylan and Abbott Laboratories' non-U.S. developed markets specialty and branded generics business, Mylan's Board of Directors determined, effective November 4, 2014, that the vesting of all unvested stock options, restricted stock units ("RSUs"), and performance restricted stock units ("PRSUs") granted to directors and executive officers as part of Mylan's ordinary course annual equity compensation program (other than incentive stock options and the options granted in 2014) would be accelerated prior to the Transaction.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.